ITeos Therapeutics Inc (ITOS)
10.60
+0.03
(+0.28%)
USD |
NASDAQ |
Apr 25, 16:00
10.60
0.00 (0.00%)
After-Hours: 20:00
ITeos Therapeutics Cash from Investing (TTM): 72.66M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 72.66M |
September 30, 2023 | -434.02M |
June 30, 2023 | -456.82M |
March 31, 2023 | -477.43M |
December 31, 2022 | -446.06M |
September 30, 2022 | -1.103M |
June 30, 2022 | -1.53M |
March 31, 2022 | -1.474M |
December 31, 2021 | -1.242M |
Date | Value |
---|---|
September 30, 2021 | -1.215M |
June 30, 2021 | -0.788M |
March 31, 2021 | -0.431M |
December 31, 2020 | -0.377M |
September 30, 2020 | -0.287M |
June 30, 2020 | -0.27M |
March 31, 2020 | -0.346M |
December 31, 2019 | -0.926M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-477.43M
Minimum
Mar 2023
72.66M
Maximum
Dec 2023
-103.04M
Average
-1.103M
Median
Sep 2022
Cash from Investing (TTM) Benchmarks
Gilead Sciences Inc | -2.265B |
Merck & Co Inc | -14.08B |
Arcus Biosciences Inc | 194.00M |
IGM Biosciences Inc | 68.36M |
Forian Inc | 7.120M |